Neurohormonal modulation and afterload reduction are essential for treating heart failure with reduced ejection fraction (HFrEF). In HFrEF patients with concomitant moderate aortic stenosis (AS), therapy with transcatheter aortic valve replacement (TAVR) may be complementary to guideline-directed medical therapy (GDMT).
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cardiac
November 26, 2024
November 26, 2024
This study compared outcomes between patients undergoing valve-in-valve transcatheter aortic valve replacement (ViV TAVR) and redo surgical aortic valve replacement (redo SAVR) using a retrospective analysis of institutional databases, which included data from 2013 to 2022 for TAVR and 2011 to 2022 for SAVR.
November 26, 2024
The EARLY TAVR trial investigators randomly assigned patients with asymptomatic severe aortic stenosis to undergo either early transfemoral transcatheter aortic valve replacement (TAVR) or clinical surveillance. The primary end point was a composite of death, stroke, or unplanned hospitalization for cardiovascular causes.
November 26, 2024
In this article, the authors detail the seven pillars for successful management of tricuspid valve endocarditis. Surgical indications for tricuspid valve endocarditis include heart failure, uncontrolled infection, and septic emboli risk.
November 25, 2024
The authors demonstrate a quadruple valve replacement in a patient with carcinoid heart disease affecting all four heart valves.
November 22, 2024
In this episode of The Beat, CTSNet EIC Joel Dunning had the opportunity to speak with Professor Mark Redmond about the ROSS procedure at the 2024 Birmingham Review Course. They discuss the current status of the ROSS procedure, the evolution of this procedure, and its benefits.
November 22, 2024
At the International Society for Minimally Invasive Cardiothoracic Surgery Annual Scientific Meeting 2024, T. Sloane Guy presented “Robotic Mitral Surgery Update.”
November 21, 2024
CTSNet continued its webinar series partnership with the ASAIO Journal on November 14, 2024, by enrolling cardiac surgery and heart failure professionals engaged to discuss the topic, "Non-LVAD and Non-CRT Device Options in Heart Failure." Panelists included Amit N. Vora, MD, MPH, FACC, FSCAI, of Yale University, and Ulrich P. Jorde, MD, of Montefiore Health System.
November 21, 2024
This cohort study, called the Real-World Observational Study for Investigating the Prevalence and Therapeutic Options for Atrial Functional Mitral Regurgitation (REVEAL-AFMR), aimed to investigate the prevalence, clinical characteristics, and outcomes of mitral valve (MV) surgery in atrial functional mitral regurgitation (AFMR).
November 21, 2024
This study utilized data from 1,266,545 consecutive isolated coronary artery bypass graft (CABG) operations (2008-2016) in The Society of Thoracic Surgeons Adult Cardiac Surgery Database to develop risk assessment tools to predict the likelihood of perioperative transfusions and the expected volume of blood products required.